TheraScan offers a simple way to initiate, update and resolve Serious Adverse Events (SAEs) that occur during a clinical trial.
TheraScan ties the regulatory requirements of assessing SAEs to the clinical needs of treating the patient and resolving the issue.
TheraScan is a HIPAA-compliant system such that documents with protected health information can be shared across the system. This allows the sponsor to work closely with the investigator in resolving a SAE. Test results, assessments, images and most any other type of supporting document can be uploaded to the system. As always, it is important to appropriately in inform study participants that their PHI will be shared with the sponsor in the event of an SAE.